Budesonide Inhaled
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
An inhaled corticosteroid used as a controller medication for persistent asthma. Available as a dry powder inhaler (Flexhaler) for older children and adults, and as a nebulizer suspension (Respules) for infants and young children. Budesonide has a favorable safety profile, including the most extensive safety data in pregnancy among all inhaled corticosteroids. Also available as an oral formulation (Entocort) for inflammatory bowel disease and as a nasal spray (Rhinocort) for allergic rhinitis.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
An inhaled corticosteroid used as a controller medication for persistent asthma. NutriStack rates the supporting evidence as strong. Common adult dosing is Flexhaler: 180-360 mcg BID (adults); Respules: 0.25-1 mg via nebulizer BID (children 12 months-8 years); titrate to lowest effective dose (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete calcium. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: controller therapy for persistent asthma (adults and children >=6 months), nebulized form for infants and young children unable to use inhalers, most pregnancy safety data of any ics. 10 sources indexed (2004–2024), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Binds to the intracellular glucocorticoid receptor and modulates inflammatory gene transcription. The activated receptor complex suppresses NF-kB and AP-1 transcription factors, reducing the production of pro-inflammatory cytokines, chemokines, and adhesion molecules. Budesonide undergoes high first-pass hepatic metabolism (~90%), resulting in low systemic bioavailability from the swallowed portion. Its high receptor affinity and lipophilic ester conjugation in airway tissue provide prolonged local anti-inflammatory effect.
Dosing & protocol.
Delivered by inhalation directly to the airways. Systemic bioavailability approximately 6-13% (Flexhaler) or 6% (Respules) due to high first-pass metabolism. Rinse mouth after use to prevent oral candidiasis. For nebulizer use, use a mouthpiece rather than face mask to reduce facial skin deposition.3
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Calcium
MildLong-term or high-dose inhaled corticosteroid exposure can reduce bone formation and contribute to poorer calcium balance.
Full safety detail.
Side effects
- Oral candidiasis (thrush)
- Dysphonia (hoarseness)
- Cough and throat irritation
- Headache
- Nasopharyngitis
- Adrenal suppression (with high-dose chronic use)
- Growth suppression in children (small effect, ~0.5 cm/year)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
3- 1Meta-analysis of combined azithromycin and inhaled budesonide treatment for Chinese pediatric patients with mycoplasma pneumoniaPMIDZhao J, Pan X, Shao P · Medicine · 2024
Zhao J, Pan X, Shao P. Meta-analysis of combined azithromycin and inhaled budesonide treatment for Chinese pediatric patients with mycoplasma pneumonia. Medicine. 2024
- 2Inhaled budesonide for the prevention of acute mountain sickness: A meta-analysis of randomized controlled trialsPMIDZhu X, Liu Y, Li N et al. · The American journal of emergency medicine · 2020
Zhu X, Liu Y, Li N et al.. Inhaled budesonide for the prevention of acute mountain sickness: A meta-analysis of randomized controlled trials. The American journal of emergency medicine. 2020
- 3Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysisPMIDMasoli M, Holt S, Weatherall M et al. · The European respiratory journal · 2004
Masoli M, Holt S, Weatherall M et al.. Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. The European respiratory journal. 2004
Randomized controlled trials
2- 4Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform TrialPMIDReis G, Dos Santos Moreira Silva EA, Medeiros Silva DC et al. · Annals of internal medicine · 2023
Reis G, Dos Santos Moreira Silva EA, Medeiros Silva DC et al.. Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial. Annals of internal medicine. 2023
- 5Inhaled Budesonide in Neonatal Respiratory Distress Syndrome of Near-Term Neonates: A Randomized, Placebo-Controlled TrialPMIDElfarargy MS, Al-Ashmawy GM, Abu-Risha SM et al. · The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2022
Elfarargy MS, Al-Ashmawy GM, Abu-Risha SM et al.. Inhaled Budesonide in Neonatal Respiratory Distress Syndrome of Near-Term Neonates: A Randomized, Placebo-Controlled Trial. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2022
Reference material
5- 6GINA (Global Initiative for Asthma). Global Strategy for Asthma Management and Prevention. 2023.Source linkedPMID
- 7Szefler SJ et al. Long-term effects of budesonide or nedocromil in children with asthma (CAMP). N Engl J Med. 2000.Source linkedPMID
- 8Kallen B et al. Use of inhaled budesonide during pregnancy and risk of congenital malformations. Obstet Gynecol. 1999.Source linkedPMID
- 9Magboul N, Alharbi AF, Alqutub AT et al.. Budesonide nasal irrigation for chronic rhinosinusitis: a meta-analysis of therapeutic outcomes and safety profile. Rhinology. 2025Source linkedPMID
- 10Beasley R, Harrison T, Peterson S et al.. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis. JAMA network open. 2022Source linkedPMID
Common questions.
Quick answers about Budesonide Inhaled, drawn from the data on this page.
What is Budesonide Inhaled?
An inhaled corticosteroid used as a controller medication for persistent asthma. Available as a dry powder inhaler (Flexhaler) for older children and adults, and as a nebulizer suspension (Respules) for infants and young children. Budesonide has a favorable safety profile, including the most extensive safety data in pregnancy among all inhaled corticosteroids. Also available as an oral formulation (Entocort) for inflammatory bowel disease and as a nasal spray (Rhinocort) for allergic rhinitis.
What is Budesonide Inhaled used for?
Commonly cited benefits of Budesonide Inhaled include: Controller therapy for persistent asthma (adults and children >=6 months); Nebulized form for infants and young children unable to use inhalers; Most pregnancy safety data of any ICS; Reduces asthma exacerbations and improves lung function; Once- or twice-daily dosing. NutriStack rates the overall evidence as strong.
What is a typical dose of Budesonide Inhaled?
A typical adult dose of Budesonide Inhaled is Flexhaler: 180-360 mcg BID (adults); Respules: 0.25-1 mg via nebulizer BID (children 12 months-8 years); titrate to lowest effective dose (as prescribed by your physician). The commonly recommended form is Dry powder inhaler (DPI) or nebulizer suspension. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Budesonide Inhaled?
Reported side effects include oral candidiasis (thrush), dysphonia (hoarseness), cough and throat irritation, headache, nasopharyngitis, adrenal suppression (with high-dose chronic use). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Budesonide Inhaled?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Budesonide Inhaled in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.